In addition, screening of a broad spectrum of biologically active molecules yielded a list of potential CYP2W1 inducers that might be instrumental for its up-regulation in cancer tissues, increasing thus the efficacy of prodrug therapy. This evidence concerns the gene CYP2W1 and cancer.